Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

OncoSynergy

OncoSynergy?uq=w9if130k
2011 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Seed LATEST DEAL TYPE
$20M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of oncology therapeutics designed to radically improve outcomes for patients with unmet needs in oncology. The company's therapeutics include a new class of oncology therapeutics called Resistance Mechanism Inhibitors (RMIs), that feature multiple simultaneous mechanisms of action and synergy, in combination with other treatments, including immunotherapies in a preclinical model, enabling oncologists to treat many types of solid and hematological cancers.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 329 Oyster Point Boulevard
  • South San Francisco, CA 94080
  • United States

+1 (415) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore OncoSynergy’s full profile, request a free trial.

OncoSynergy Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 14-May-2018 $20M 000.00 0000 Completed Generating Revenue
4. Accelerator/Incubator 19-May-2017 000.00 Completed Generating Revenue
3. Accelerator/Incubator 000.00 Completed Generating Revenue
2. Merger/Acquisition 05-Apr-2016 Cancelled Generating Revenue
1. Angel (individual) 28-Jun-2015 $10.2M $10.2M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

OncoSynergy Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

OncoSynergy Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Connecticut Innovations Venture Capital Minority 000 0000 000000 0
Korea Information & Communications Company Corporation Minority 000 0000 000000 0
NLabs Family Office Minority 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator Minority 000 0000 000000 0

OncoSynergy Executive Team (3)

Name Title Board
Seat
Contact
Info
W. Shawn Carbonell Ph.D Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member
Anne-Marie Carbonell Co-Founder & Acting Chief Medical Officer
Catherine Park MD Co-Founder

OncoSynergy Board Members (3)

Name Representing Role Since Contact
Info
Allen Salmasi Ph.D NLabs Board Member 000 0000
Hen-Suh Park Ph.D OncoSynergy Board Member 000 0000
Robert Dunkle OncoSynergy Board Member 000 0000